BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Olsen RS, Nijm J, Andersson RE, Dimberg J, Wågsäter D. Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer. World J Gastroenterol 2017; 23(34): 6212-6219 [PMID: 28974887 DOI: 10.3748/wjg.v23.i34.6212]
URL: https://www.wjgnet.com/1007-9327/full/v23/i34/6212.htm
Number Citing Articles
1
Shainan Hora, Amit Kumar Pandey, Sudhakar Jha. Neoplasm2018;  doi: 10.5772/intechopen.78377
2
Mona S Abdellateif, Salem E Salem, Doaa M Badr, Sabry Shaarawy, Marwa M Hussein, Abdel-Rahman Zekri, Mariam A Fouad. The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer PatientsJournal of Inflammation Research 2020; : 1245 doi: 10.2147/JIR.S283069
3
Oscar J. Cordero, Rubén Varela-Calviño, Begoña Graña-Suárez. Cancer Immunology2020; : 261 doi: 10.1007/978-3-030-57949-4_10
4
Hassan Ashktorab, Akbar Soleimani, Alexandra Nichols, Komal Sodhi, Adeyinka O. Laiyemo, Gail Nunlee-Bland, Seyed Mehdi Nouraie, Hassan Brim. Adiponectin, Leptin, IGF-1, and Tumor Necrosis Factor Alpha As Potential Serum Biomarkers for Non-Invasive Diagnosis of Colorectal Adenoma in African AmericansFrontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00077
5
Tonje Bjørnetrø, Lilly Alice Steffensen, Beate Vestad, Berit Sletbakk Brusletto, Ole Kristoffer Olstad, Anne‐Marie Trøseid, Hans Christian Dalsbotten Aass, Kari Bente Foss Haug, Alicia Llorente, Stig Ove Bøe, Anna Lång, Rampradeep Samiappan, Kathrine Røe Redalen, Reidun Øvstebø, Anne Hansen Ree. Uptake of circulating extracellular vesicles from rectal cancer patients and differential responses by human monocyte culturesFEBS Open Bio 2021; 11(3): 724 doi: 10.1002/2211-5463.13098
6
Xiduan Wei, Jingjia Ye, Yameng Pei, Chunting Wang, Hongzhen Yang, Jingyuan Tian, Guangxu Si, Yao Ma, Kun Wang, Gang Liu. Extracellular vesicles from colorectal cancer cells promote metastasis via the NOD1 signalling pathwayJournal of Extracellular Vesicles 2022; 11(9) doi: 10.1002/jev2.12264
7
Fabio Grizzi, Gianluca Basso, Elena Monica Borroni, Tommaso Cavalleri, Paolo Bianchi, Sanja Stifter, Maurizio Chiriva-Internati, Alberto Malesci, Luigi Laghi. Evolving notions on immune response in colorectal cancer and their implications for biomarker developmentInflammation Research 2018; 67(5): 375 doi: 10.1007/s00011-017-1128-1
8
Marjorie De la Fuente López, Glauben Landskron, Daniela Parada, Karen Dubois-Camacho, Daniela Simian, Maripaz Martinez, Diego Romero, Juan Carlos Roa, Isidora Chahuán, Rocío Gutiérrez, Francisco Lopez-K, Karin Alvarez, Udo Kronberg, Sebastian López, Antonella Sanguinetti, Natalia Moreno, Mario Abedrapo, María-Julieta González, Rodrigo Quera, Marcela A Hermoso-R. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancerTumor Biology 2018; 40(11): 101042831881005 doi: 10.1177/1010428318810059
9
Sara Cabrero-de las Heras, Eva Martínez-Balibrea. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancerWorld Journal of Gastroenterology 2018; 24(42): 4738-4749 doi: 10.3748/wjg.v24.i42.4738
10
Monika Zajkowska, Barbara Mroczko. Eotaxins and Their Receptor in Colorectal Cancer—A Literature ReviewCancers 2020; 12(6): 1383 doi: 10.3390/cancers12061383
11
M. Stayoussef, X. Weili, A. Habel, M. Barbirou, S. Bedoui, A. Attia, Y. Omrani, K. Zouari, H. Maghrebi, W. Y. Almawi, B. Bouhaouala-Zahar, A. Larbi, B. Yacoubi-Loueslati. Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcomeCancer Immunology, Immunotherapy 2024; 73(9) doi: 10.1007/s00262-024-03746-x
12
S. O. Gening, A. A. Rizvanov, T. V. Abakumova, D. R. Dolgova, D. U. Gafurbaeva, A. R. Rakhmatullina, I. I. Antoneeva, T. P. Gening. RELATIONSHIP BETWEEN THE BLOOD LEVELS OF INFLAMMATORY CYTOKINES AND THE NUMBER OF CIRCULATING TUMOR CELLS WITH RESPONSE TO STANDARD CHEMOTHERAPY IN PATIENTS WITH OVARIAN CANCERSiberian journal of oncology 2021; 20(1): 62 doi: 10.21294/1814-4861-2021-20-1-62-73
13
Chen Chang, Ruping Cai, Qiang Wu, Qiang Su. Uncovering the Genetic Link between Acute Myocardial Infarction and Ulcerative Colitis Co-Morbidity through a Systems Biology ApproachCardiovascular Innovations and Applications 2023; 8(1) doi: 10.15212/CVIA.2023.0034
14
Long Jin, Yu-Liang Pan, Jun Zhang, Pei-Guo Cao. LncRNA HOTAIR recruits SNAIL to inhibit the transcription of HNF4α and promote the viability, migration, invasion and EMT of colorectal cancerTranslational Oncology 2021; 14(4): 101036 doi: 10.1016/j.tranon.2021.101036
15
Marcelo G. Kazanietz, Michael Durando, Mariana Cooke. CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and BeyondFrontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00471
16
Qian Zou, Xue Lei, Aijing Xu, Ziqi Li, Qinglian He, Xiujuan Huang, Guangxian Xu, Faqing Tian, Yuanlin Ding, Wei Zhu. Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancerFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.724139
17
Wenjie Zhu, Changlei Wu, Shiqi Hu, Sicheng Liu, Shimin Zhao, Dongdong Zhang, Guisheng Qiu, Xiufeng Cheng, Jun Huang. Chemokine- and chemokine receptor-based signature predicts immunotherapy response in female colorectal adenocarcinoma patientsScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-48623-2
18
Guolin Zhang, Xin Luo, Wei Zhang, Engeng Chen, Jianbin Xu, Fei Wang, Gaoyang Cao, Zhenyu Ju, Dongai Jin, Xuefeng Huang, Wei Zhou, Zhangfa Song. CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal CancerCancer Research and Treatment 2020; 52(2): 622 doi: 10.4143/crt.2019.593
19
Vincenzo Ricci, Cristina Granetto, Antonella Falletta, Matteo Paccagnella, Andrea Abbona, Elena Fea, Teresa Fabozzi, Cristiana Lo Nigro, Marco Carlo Merlano. Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenibWorld Journal of Gastrointestinal Oncology 2020; 12(3): 301-310 doi: 10.4251/wjgo.v12.i3.301
20
Yong-Xia Li, Jian-Ying Chang, Ming-Yuan He, He-Ran Wang, Dai-Qin Luo, Feng-Hu Li, Jie-Hui Li, Li Ran, Reza Izadpanah. Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical CancerJournal of Oncology 2021; 2021: 1 doi: 10.1155/2021/2939162
21
Ti’ara L. Griffen, Eric B. Dammer, Courtney D. Dill, Kaylin M. Carey, Corey D. Young, Sha’Kayla K. Nunez, Adaugo Q. Ohandjo, Steven M. Kornblau, James W. Lillard. Multivariate transcriptome analysis identifies networks and key drivers of chronic lymphocytic leukemia relapse risk and patient survivalBMC Medical Genomics 2021; 14(1) doi: 10.1186/s12920-021-01012-y
22
Mingfu Tong, Huimin Liu, Huan Xu, Shenying Liu, Yangyang Hu, Zhizhi Wang, Youxiang Chen, Jian Wang. Clinical significance of peripheral blood-derived inflammation markers combined with serum eotaxin-2 in human colorectal cancerBiotechnology and Genetic Engineering Reviews 2024; 40(3): 1774 doi: 10.1080/02648725.2023.2196491
23
Sung-Jig Lim. Tumor MicroenvironmentAdvances in Experimental Medicine and Biology 2021; 1302: 91 doi: 10.1007/978-3-030-62658-7_7
24
Jan Dimberg, Levar Shamoun, Kalle Landerholm, Dick Wågsäter. Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancerWorld Journal of Gastroenterology 2022; 28(19): 2148-2151 doi: 10.3748/wjg.v28.i19.2148
25
Jan Korbecki, Donata Simińska, Klaudyna Kojder, Szymon Grochans, Izabela Gutowska, Dariusz Chlubek, Irena Baranowska-Bosiacka. Fractalkine/CX3CL1 in Neoplastic ProcessesInternational Journal of Molecular Sciences 2020; 21(10): 3723 doi: 10.3390/ijms21103723
26
Nana Sugamata, Takashi Okuyama, Emiko Takeshita, Haruka Oi, Yuhei Hakozaki, Shunya Miyazaki, Musashi Takada, Takashi Mitsui, Takuji Noro, Hideyuki Yoshitomi, Masatoshi Oya. Surgical site infection after laparoscopic resection of colorectal cancer is associated with compromised long-term oncological outcomeWorld Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02578-2
27
Lauren C. Peres, Mary K. Townsend, Brenda M. Birmann, Jose R. Conejo-Garcia, Yongjoo Kim, Laura D. Kubzansky, Larry I. Magpantay, Otoniel Martinez-Maza, Shelley S. Tworoger. Circulating Biomarkers of Inflammation and Ovarian Cancer Risk in the Nurses' Health StudiesCancer Epidemiology, Biomarkers & Prevention 2021; 30(4): 710 doi: 10.1158/1055-9965.EPI-20-1390
28
Sheng-Nan Jia, Ying-Bo Han, Rui Yang, Ze-Cheng Yang. Chemokines in colon cancer progressionSeminars in Cancer Biology 2022; 86: 400 doi: 10.1016/j.semcancer.2022.02.007
29
María del Rosario Huizar-López, Anne Santerre, Jaime Coronilla-Martínez, Xóchitl Rocío Ávila-Dávila, Pablo Cesar Ortiz-Lazareno, Josefina Casas-Solís. Annona muricata ethanolic extract protects BALB/c mice against colitis-associated colon cancer through modulation of cytokine levels and KRAS and APC expressionAdvances in Traditional Medicine 2024;  doi: 10.1007/s13596-024-00798-3
30
Oscar J. Cordero, Rubén Varela-Calviño, Begoña Graña-Suárez, Alba García-López. Foundations of Colorectal Cancer2022; : 435 doi: 10.1016/B978-0-323-90055-3.00031-4
31
Rihab Nasr, Miza Salim Hammoud, Farah Nassar, Deborah Mukherji, Ali Shamseddine, Sally Temraz. Inflammatory Markers and MicroRNAs: The Backstage Actors Influencing Prognosis in Colorectal Cancer PatientsInternational Journal of Molecular Sciences 2018; 19(7): 1867 doi: 10.3390/ijms19071867
32
Iwona Bednarz-Misa, Dorota Diakowska, Izabela Szczuka, Paulina Fortuna, Agnieszka Kubiak, Joanna Rosińczuk, Małgorzata Krzystek-Korpacka. Interleukins 4 and 13 and Their Receptors Are Differently Expressed in Gastrointestinal Tract Cancers, Depending on the Anatomical Site and Disease Advancement, and Improve Colon Cancer Cell Viability and MotilityCancers 2020; 12(6): 1463 doi: 10.3390/cancers12061463
33
Jialing Hu, Yingcheng He, Kaili Liao, Qijun Yang, Yuhan Xu, Gaoquan Cao, Xiaozhong Wang. Identification of inflammatory factor-related genes associated with the prognosis and immune cell infiltration in colorectal cancer patientsGenes & Diseases 2023; 10(5): 2109 doi: 10.1016/j.gendis.2022.07.015
34
Xiaowan Yin, Zhuo Wang, Tong Wu, Meichen Ma, Zining Zhang, Zhenxing Chu, Qinghai Hu, Haibo Ding, Xiaoxu Han, Junjie Xu, Hong Shang, Yongjun Jiang. The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progressionJournal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-02172-3